128 related articles for article (PubMed ID: 6240671)
1. Measurement of 24-hour whole-body retention of Tc-99mMDP with a thyroid uptake probe: quantitative assessment of metabolic and metastatic bone diseases.
Seto H; Futatsuya R; Ihara F; Kamei T; Furumoto N; Ishizaki Y; Hada M; Kakishita M
Radiat Med; 1984; 2(2):87-92. PubMed ID: 6240671
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of 24-hr whole-body retention of 99mTc-MDP with a thyroid uptake probe (author's transl)].
Seto H; Kakishita M; Futatsuya R
Radioisotopes; 1981 May; 30(5):263-7. PubMed ID: 6458840
[TBL] [Abstract][Full Text] [Related]
3. Diphosphonates in the evaluation of metabolic bone disease.
Fogelman I; Smith ML
Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
[TBL] [Abstract][Full Text] [Related]
4. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
5. [Whole-body retention of 99mTc-methylene diphosphonate in skeletal diseases].
Zorn-Bopp E; Büll U; Münzing W; Lang P; Moser EA
Nuklearmedizin; 1983 Feb; 22(1):24-30. PubMed ID: 6223277
[TBL] [Abstract][Full Text] [Related]
6. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
Fogelman I; Bessent RG; Turner JG; Citrin DL; Boyle IT; Greig WR
J Nucl Med; 1978 Mar; 19(3):270-5. PubMed ID: 564941
[TBL] [Abstract][Full Text] [Related]
7. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.
Molloi S; Mazess R; Bendsen H; Wilson M
Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with two simple methods of measurement of 99mTc-methylene diphosphonate body retention in bone disease.
Reschini E; Ulivieri FM; Ortolani S
J Nucl Biol Med (1991); 1991; 35(3):123-30. PubMed ID: 1816867
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative whole-body skeletal scintigraphy with a gamma camera and pinhole collimator].
Anger K; Köhnen H; Stockberg H; Traut A; Winandi R
Nuklearmedizin; 1985 Feb; 24(1):2-6. PubMed ID: 3158885
[TBL] [Abstract][Full Text] [Related]
11. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.
Martin W; Fogelman I; Bessent RG
J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
Rudd TG; Allen DR; Smith FD
J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
[TBL] [Abstract][Full Text] [Related]
13. Quantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinoma.
Sundkvist GM; Ahlgren L; Lilja B; Mattsson S
Nuklearmedizin; 1992 Oct; 31(5):178-81. PubMed ID: 1465355
[TBL] [Abstract][Full Text] [Related]
14. Diphosphonate bone scanning agents--current concepts.
Fogelman I
Eur J Nucl Med; 1982; 7(11):506-9. PubMed ID: 6217074
[TBL] [Abstract][Full Text] [Related]
15. Measurement of 24 hour whole body retention of 99Tcm-diphosphonate by a single thyroid probe.
Lang P; Büll U
Nucl Med Commun; 1984 Oct; 5(10):627-32. PubMed ID: 6442403
[TBL] [Abstract][Full Text] [Related]
16. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
Nakano S; Hasegawa Y; Kajita A; Nakamura S; Horai T; Ikegami H; Matuda M; Okamoto N; Nabeshima H; Doi O; Komatubara Y; Ishigami S
Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314
[No Abstract] [Full Text] [Related]
17. Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate.
Rajapakse C; Thompson R; Grennan DM; Winston BM; Patel P; Nuttall PM; Murphy J; Weiss JB
Ann Rheum Dis; 1983 Apr; 42(2):138-41. PubMed ID: 6221703
[TBL] [Abstract][Full Text] [Related]
18. Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging.
Simon MA; Kirchner PT
J Bone Joint Surg Am; 1980 Jul; 62(5):758-64. PubMed ID: 6446566
[TBL] [Abstract][Full Text] [Related]
19. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
20. Increased skeletal:renal uptake ratio: etiology and characteristics.
Cheng TH; Holman BL
Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
